Anticoagulants

Global Industry Analysts
October 1, 2012
434 Pages - SKU: GJOB4921030
Sickle Cell Disease Global Clinical Trials Review, H2, 2014
8/20/2014 | published by: GlobalData
Sickle Cell Disease Global Clinical Trials Review, H2, 2014 Summary GlobalData's clinical trial report, “Sickle Cell Disease Global Clinical Trials Review, H2, 2014 provides data on the Sickle Cell Disease clinical trial scenario. This report provides elemental  |  read more...
USD 2,500
Physician Views: As race to market intensifies, how expectant are cardiologists for PCSK9 inhibitor class?
8/7/2014 | published by: FirstWord
The race to successfully deliver a PCSK9 inhibitor to market for the treatment of hypercholesterolaemia intensified last week with Sanofi and Regeneron Pharmaceuticals unveiling a raft of new late-stage data for their antibody alirocumab. Furthermore, via  |  read more...
USD 645
Coronary Stenosis Global Clinical Trials Review, H2, 2014
8/20/2014 | published by: GlobalData
Coronary Stenosis Global Clinical Trials Review, H2, 2014 Summary GlobalData's clinical trial report, “Coronary Stenosis Global Clinical Trials Review, H2, 2014 provides data on the Coronary Stenosis clinical trial scenario. This report provides elemental information and data  |  read more...
USD 2,500
Chemotherapy Induced Anemia - Pipeline Review, H2 2014
8/25/2014 | published by: Global Markets Direct
Chemotherapy Induced Anemia - Pipeline Review, H2 2014 Summary Global Markets Direct’s, ‘Chemotherapy Induced Anemia - Pipeline Review, H2 2014’, provides an overview of the Chemotherapy Induced Anemia’s therapeutic pipeline. This report provides comprehensive information on the therapeutic  |  read more...
USD 2,000
Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD) - Pipeline Review, H2 2014
7/15/2014 | published by: Global Markets Direct
Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD) - Pipeline Review, H2 2014 Summary Global Markets Direct’s, ‘Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD) - Pipeline Review, H2 2014’, provides an overview of the Peripheral Arterial  |  read more...
USD 2,000
Myocardial Infarction - Pipeline Review, H2 2014
7/15/2014 | published by: Global Markets Direct
Myocardial Infarction - Pipeline Review, H2 2014 Summary Global Markets Direct’s, ‘Myocardial Infarction - Pipeline Review, H2 2014’, provides an overview of the Myocardial Infarction’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Myocardial  |  read more...
USD 2,000
Familial Hypercholesterolemia (Type II Hyperlipoproteinemia) - Pipeline Review, H2 2014
7/15/2014 | published by: Global Markets Direct
Familial Hypercholesterolemia (Type II Hyperlipoproteinemia) - Pipeline Review, H2 2014 Summary Global Markets Direct’s, ‘Familial Hypercholesterolemia (Type II Hyperlipoproteinemia) - Pipeline Review, H2 2014’, provides an overview of the Familial Hypercholesterolemia (Type II Hyperlipoproteinemia)’s therapeutic pipeline. This report  |  read more...
USD 2,000
Hypercholesterolemia Partnering 2009-2014
8/1/2014 | published by: Current Partnering
Hypercholesterolemia Partnering 2009-2014 Hypercholesterolemia Partnering 2009-2014 provides understanding and access to the hypercholesterolemia partnering deals and agreements entered into by the worlds leading healthcare companies. The report provides an analysis of hypercholesterolemia partnering deals. The majority of  |  read more...
USD 995
Congestive Heart Failure Partnering 2009-2014
8/1/2014 | published by: Current Partnering
Congestive Heart Failure Partnering 2009-2014 Congestive Heart Failure Partnering 2009-2014 provides understanding and access to the congestive heart failure partnering deals and agreements entered into by the worlds leading healthcare companies. The report provides an analysis of  |  read more...
USD 995
Stroke Partnering 2009-2014
8/1/2014 | published by: Current Partnering
Stroke Partnering 2009-2014 The Stroke Partnering 2009-2014 provides understanding and access to the stroke partnering deals and agreements entered into by the worlds leading healthcare companies. The report provides an analysis of stroke partnering deals. The  |  read more...
USD 995
 

SELECT A LICENSE

    PDF E-mail From Publisher  USD 4,950  
 
US: 800.298.5699
Int'l: +1.240.747.3093
 

Share this report


    Other tasks

     
     
    Join Alert Me now!
    Receive bi-weekly email alerts on new market research

    Sign up today!